drugset / Trial / NCT03037515

Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery

NCT03037515

Phase 4 Completed 83 enrolled Henry Ford Health System
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this project is to compare the effectiveness of two different but well accepted routes of administration of tranexamic acid in order to reduce blood loss and need for transfusion in patients undergoing lumbar spine surgery. Specifically, this study seeks to identify if intravenous tranexamic acid is superior to oral tranexamic acid in reducing blood loss and need for transfusion.

Timeline

Start
2017-02-15
Primary completion
2018-06-15
Completion
2018-07-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous
Comparator Tranexamic Acid Small molecule 1950 mg Intravenous

Indications